All Inventory

Stable arginate salt of Body Protection Compound formulated for GI-tract delivery and gut-lining research.

Lys-Pro-Val α-MSH fragment in enteric capsules for inflammatory-barrier and mast-cell pathway research.

GLP-1 receptor agonist troche dissolved under the tongue for incretin and appetite-axis research models.

Dual GIP / GLP-1 co-agonist troche format for sublingual-absorption and metabolic-signaling research.

Nicotinamide adenine dinucleotide capsules studied for mitochondrial energy, sirtuin and longevity pathways.

Pharmaceutical-grade methylene blue capsules studied for mitochondrial electron-transport support.

Tauroursodeoxycholic acid capsules studied for hepatobiliary support and ER-stress research.

Reduced L-glutathione troche format for sublingual antioxidant-pathway research.

Copper-bound tripeptide studied for collagen synthesis, wound remodeling and follicle support.

Pre-formulated topical GHK-Cu serum for ex-vivo skin and scalp research.

GHK-Cu / BPC-157 / TB-500 blend studied for skin regeneration and topical recovery models.

Synthetic α-MSH analog studied in melanogenesis and pigmentation models.

Tetrapeptide studied for pineal function and telomerase expression in longevity models.

Coenzyme studied in mitochondrial energy, sirtuin signaling and cellular aging.

Mitochondria-targeted tetrapeptide studied for cardiolipin stabilization.

Master antioxidant tripeptide studied in oxidative-stress and detox pathway models.

Mitochondrial-derived peptide studied for metabolic flexibility and AMPK signaling.

28-amino-acid thymic peptide studied for immune modulation and T-cell maturation.

Thymalin-class polypeptide complex studied for immuno-senescence research.

Long-acting GLP-1 receptor agonist studied for glycemic and appetite regulation.

Dual GIP / GLP-1 receptor agonist studied for combined incretin signaling.

Triple GIP / GLP-1 / glucagon agonist studied for lipid and energy expenditure.

Fragment 176–191 of hGH studied for lipolysis without growth-related effects.

GHRH analog studied for visceral adipose reduction and lipid metabolism.

GHRH + GHRP blend studied for synergistic GH pulse research.

Body Protection Compound studied for tendon, ligament and gut-lining repair models.

Actin-binding peptide fragment studied for soft-tissue repair and vascularization.

BPC-157 / KPV combination studied for accelerated repair and inflammation modulation.

Tripeptide fragment of α-MSH studied for gut and inflammatory-response models.

Antimicrobial cathelicidin peptide studied for innate-immunity and wound research.

Erythropoietin-derived peptide studied for tissue protection and neuropathy models.

28-amino-acid neuropeptide studied for vasodilation and anti-inflammatory pathways.

GHRH + ghrelin-mimetic blend studied for endogenous GH pulse research.

ACTH-derived heptapeptide studied for cognition and neuroprotection models.

Tuftsin analog studied for anxiolytic and immunomodulatory effects.

Nonapeptide studied for sleep regulation and stress-axis modulation.

GPR54 agonist studied for HPG-axis activation and reproductive endocrinology.

Melanocortin agonist studied for libido and arousal-pathway research.